Cannabis prescribing guidelines spark concern
Australia’s first cannabis prescribing guidelines have been described as mysterious, unjustified, and not supported by evidence.
The 29-page document from the Queensland health department, made public on Australia Day, provides guidance on sourcing, doses and regimens.
The guidelines focus on treatment of drug-resistant epilepsy in children, and symptom control in palliative care, chemotherapy and multiple sclerosis.
Yet a puzzled Dr Evan Ackermann, chair of the RACGP’s Expert Committee on Quality Care, says they have “no justification in evidence”.